Biologists have uncovered a surprising connection between the way plants grow and how they defend themselves against ...
As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally. However, the Company can give no assurance that the ADS trading price after the ADS Ratio Change will ...
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...
Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...
Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...
NEW YORK - Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical-stage biotechnology company with a market capitalization of approximately $13 million, has received authorization from Health Canada to ...
Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...
Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...
IR700 is being investigated in several other therapeutic modalities targeting diseases such as ocular melanoma and bladder cancer Rakuten Medical strengthens its technology platform and business ...
A webcast of the presentation will be available on the Events and Presentations page of Q32 Bio's website at . Archived replays will be available for 90 days following the event. Q32 Bio is a clinical ...
Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the ...
CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...